Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Shukra Pharmaceuticals Ltd - Board Meeting Intimation for Considering And Approving Audited Financial Result For The Quarter And Financial Year Ended March 31, 2023 And Other Businesses.
Download announcement < Back
19 May 2023
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve 1. Audited financial result for the quarter and financial year ended on 31st March, 2023 along with the Auditor&apos;&apos;s Report and Certificate for unmodified opinion Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015. 2. Recommend final dividend to the members of the company for the financial year 2022-23. 3. Any other business with the permission of Chairman.
View all announcements for Shukra Pharmaceuticals Ltd Source: BSE India

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips